This ADC may induce significant ADCC against TROP2-positive endometrial cancer cells in the presence of effector cells (i.e., NK cells), and additionally, Dato-DXd allows for a significant bystander killing effect, which may aid in the treatment of tumors with heterogeneous antigen expression. Here, TACSTD2 is linked to endometrial cancer.